Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Ambrx Biopharma Inc.
Headquarters: La Jolla, CA, United States of America
Website: N/A
Year Founded: 2003
Status: Acquired
BioCentury | Feb 3, 2024
Finance
Series A companies: the class of 2023
An analysis of the technologies behind last year’s biotech series A raisers finds clusters in mitophagy induction, epigenome editing and delivery vectors
BioCentury | Jan 13, 2024
Finance
JPM wrap: a BioCentury podcast
Takeouts, neuroscience innovation and investor sentiment to kick off 2024
BioCentury | Jan 12, 2024
Finance
The year of biotech’s recovery
Public Markets Preview: Investors say biotech outperformance in 2024 will hinge on the interest rate environment
BioCentury | Jan 8, 2024
Deals
Ambrx turnaround culminates in $2B takeout by J&J
A fall 2022 reset positioned an ADC for prostate cancer as the biotech’s top priority under new leadership
BioCentury | May 23, 2023
Management Tracks
Coelho succeeds Lankry as Gamida CFO
Plus: Sullivan becomes chief strategy officer at BioAge, and updates from Athira, Ambrx and FNIH
BioCentury | Feb 3, 2023
Management Tracks
Vessey to leave BMS in July
Plus: Nichols joining enGene as CEO and updates from Invivyd, Exai and more
BioCentury | Dec 10, 2022
Product Development
Dec. 9 Quick Takes: Trio of biotechs parlays data into follow-ons
Plus: Erasca adds pan-RAF inhibitor from Novartis, and updates from UCB, Ambrx, Pharvaris and more
BioCentury | Nov 2, 2022
Management Tracks
Cox to head digital health at Pfizer
Plus Stegmeier joins Curie Bio and updates from Actinium, Lexeo and more
BioCentury | Aug 16, 2022
Management Tracks
Simcha hires CEO, expands research agreement
Plus Integra’s Caruso passes away and updates from Ambrx, Cullinan, Zephyr, South Rampart and more
BioCentury | May 18, 2022
Management Tracks
Fromen to leave PacBio as CCO
Plus Vraniak joins Inversago as CFO and updates from Thabor, Glympse, Civetta and more
Items per page:
1 - 10 of 16